Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifampin for SCV-SA in Cystic Fibrosis
NCT02547116Phase 4Withdrawn
- Sponsor
- Johns Hopkins University
- Start
- Dec 2020
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rifampicin in Staphylococcus aureus infection, sponsored by Johns Hopkins University. Planned start Dec 2020; status: withdrawn.
02
Drugs
rifampicin
03
Conditions
Staphylococcus aureus infection
Beyond the preview
Go deeper on NCT02547116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02547116.